Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||The fate of the aortofemoral graft|
|Citation:||European Journal of Vascular Surgery, 1995; 9(1):97-102|
|Publisher:||W B SAUNDERS CO LTD|
|Raptis, S. ; Faris, I. ; Miller, J. ; Quigley, F.|
|Abstract:||<h4>Objective</h4>To determine the incidence and cause for reoperation following aortofemoral bypass surgery.<h4>Design</h4>This paper describes the results of all aortofemoral grafts performed in the years 1978-1991, 251 of these patients underwent an aortobifemoral graft (ABF) whilst the remaining 50 had an aortounifemoral graft (AUF).<h4>Results</h4>The aortofemoral bypass was the only operation performed in fewer than half of the patients. Sixteen per cent of ABF and 50% of the AUF patients had surgery before the index operation. Subsequently 33% of the ABF patients and 60% of the AUF group had one or more additional vascular procedures. Graft infections and false aneurysms continued to present in about 1% patients per year at least up to 10 years following surgery. The 5 year actuarial survival was 73% in the ABF group and 38% in the AUF patients. The primary patency at 5 years was 85% in the ABF patients and 81% in the AUF group. Amputation was performed in 6% of the ABF patients and in 20% of the AUF patients.<h4>Conclusions</h4>The frequent need for later surgery (1:3 for the ABF patients) should be considered in the decision to undertake the initial aortofemoral operation when the patient presents with intermittent claudication.|
|Keywords:||Aorta, Abdominal; Femoral Artery; Iliac Artery; Humans; Aneurysm, False; Intermittent Claudication; Postoperative Complications; Treatment Outcome; Arteriovenous Shunt, Surgical; Reoperation; Morbidity; Incidence; Follow-Up Studies; Blood Vessel Prosthesis; Vascular Patency; Time Factors; Middle Aged; Female; Male|
|Appears in Collections:||Surgery publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.